Understanding how two related mammalian histone acetyl transferase co-activators, SAGA and ATAC, differentially regulate chromatin dynamics and transcription
了解两种相关的哺乳动物组蛋白乙酰转移酶共激活剂 SAGA 和 ATAC 如何差异调节染色质动力学和转录
基本信息
- 批准号:10092202
- 负责人:
- 金额:$ 34.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcetyltransferaseAffectAgingBindingBiochemicalBiochemistryBiophysicsCardiac MyocytesCatalytic DomainCellsCellular biologyChromatinChromatin StructureComplexDNA RepairDNA biosynthesisDataDevelopmentDiseaseDrosophila genusDrug resistanceEnhancersEnsureEpigenetic ProcessFluorescenceFoundationsGene Expression RegulationGenesGeneticGenetic TranscriptionGenomeGenome StabilityHIVHeart DiseasesHistone AcetylationHistonesHumanIn VitroIndividualKnock-outKnowledgeMalignant NeoplasmsMammalian CellMessenger RNAMethodsModificationMolecularMultiprotein ComplexesMusMutagenesisMutationN-terminalNatureNucleosomesPeptidesPharmacotherapyPost-Translational Protein ProcessingPropertyProtein SubunitsProteinsPublishingReaderReadingRecombinantsRegulationResearchSAGASiteStructureTailTechniquesTranscription CoactivatorTranscriptional RegulationTransferaseTranslationsWorkWritingXCL1 genebasedesignembryonic stem cellepigenetic drugepigenetic therapygenome-widegenome-wide analysishistone acetyltransferasein vivoinsightmultidisciplinarymutantnerve stem cellnovel therapeuticspreferencepreservationpromoterprotein functionsingle moleculesuccesstumorigenesis
项目摘要
UNDERSTANDING HOW TWO RELATED HISTONE ACETYL TRANSFERASE CO-ACTIVATORS, SAGA
AND ATAC, DIFFERENTIALLY REGULATE CHROMATIN DYNAMICS AND TRANSCRIPTION
PROJECT SUMMARY
Histone post translational modifications (PTMs) and the complexes that install them and read them, control
many aspects of eukaryotic genome function including transcription, DNA repair and replication. As a result of
histone PTM writer’s broad functions, they are essential in organismal development, aging and numerous
diseases including cancer, heart disease, and even HIV integration. The majority of histone writers target the
disordered N-terminal tail regions. Numerous histone writers have been identified and studied genetically,
biochemically and structurally. Surprisingly, mechanistic studies are primarily limited to interactions between
histone tail peptides and catalytic subunits, resulting in key gaps in understanding how histone readers/writers
within their full native complexes interact and regulate chromatin structure, dynamics, accessibility and
transcription. Recently, we developed the methods to purify biochemical quantities of endogenous human
SAGA and ATAC complexes, which are related, but functionally distinct essential transcription co-activators.
This allows us to quantitatively investigate how these two large multi-subunit complexes function relative to
their common catalytic subunit, KAT2A, alone. Leveraging this, we recently found that
(i) The endogenous SAGA and ATAC complexes acetylate histone octamers much more efficiently than the
KAT2A acetyltransferase alone. (ii) The acetylation efficiency of endogenous SAGA and ATAC complexes are
dramatically inhibited by unmodified nucleosomes relative to unmodified histone octamer. (iii) The SAGA and
ATAC HAT modules acetylate histone H3K9 similarly relative to KAT2A alone, but the SAGA HAT module
acetylates H3K9 in unmodified nucleosomes much more efficiently than the ATAC HAT complex or KAT2A
alone. (iv) In mouse ES cells, deletion of the SAGA HAT module does not strongly affect global H3K9
acetylation, while deletion of the ATAC HAT module results in a significant reduction in overall H3K9
acetylation.
These findings have led us to investigate the hypothesis that histone PTM readers/writers target chromatin
properties through their accessory proteins to dynamically influence chromatin dynamics and accessibility.
(1) Determine the chromatin properties that regulate reading and writing by the mammalian HAT complex
SAGA.
(2) Elucidate how the different subunits of the related mammalian HAT complexes, SAGA and ATAC,
differentially control their targeting and chromatin modifying activity.
(3) Determine the functional differences between SAGA and ATAC in mouse embryonic stem cells and during
their differentiation.
Together these aims provide a mechanistic and functional foundation for understanding of how two key
transcriptional co-activators, SAGA and ATAC, differentially regulate chromatin dynamic and transcription.
了解两种相关的组蛋白乙酰转移酶共激活剂,佐贺
和ATAC,差异调节染色质的染色质构象和转换
项目摘要
组蛋白翻译后修饰(PTM)和安装它们并读取它们的复合物,
真核生物基因组功能的许多方面,包括转录、DNA修复和复制。的结果
组蛋白PTM作家的广泛功能,他们是必不可少的生物体发育,老化和众多
包括癌症,心脏病,甚至艾滋病毒的整合。大多数组蛋白作者的目标是
无序的N-末端尾部区域。许多组蛋白作者已被确定和遗传学研究,
在生物化学和结构上。令人惊讶的是,机制研究主要限于
组蛋白尾肽和催化亚基,导致理解组蛋白读者/作家如何
在其完整的天然复合物内相互作用并调节染色质结构、动力学、可及性和
转录。近年来,我们发展了纯化内源性人体生化量的方法,
佐贺和ATAC复合物,它们是相关的,但功能不同的必需转录共激活因子。
这使我们能够定量研究这两个大的多亚基复合物相对于
它们共同的催化亚基KAT 2A。利用这个,我们最近发现,
(i)内源性佐贺和ATAC复合物乙酰化组蛋白八聚体比乙酰化组蛋白八聚体更有效。
单独的KAT 2A乙酰转移酶。(ii)内源性佐贺和ATAC复合物的乙酰化效率为
相对于未修饰的组蛋白八聚体,未修饰的核小体显著抑制。(iii)佐贺和
ATAC HAT模块相对于单独的KAT 2A类似地乙酰化组蛋白H3 K9,但是佐贺HAT模块
乙酰化未修饰核小体中的H3 K9比ATAC HAT复合物或KAT 2A更有效
一个人(iv)在小鼠ES细胞中,佐贺HAT模块的缺失不会强烈影响全局H3 K9
乙酰化,而ATAC HAT模块的缺失导致总体H3 K9
乙酰化
这些发现使我们研究了组蛋白PTM阅读器/写入器靶向染色质的假设
通过其辅助蛋白质的性质,动态地影响染色质动力学和可及性。
(1)确定哺乳动物HAT复合物调控阅读和写的染色质特性
佐贺。
(2)阐明相关哺乳动物HAT复合物佐贺和ATAC的不同亚基,
差异地控制它们的靶向和染色质修饰活性。
(3)确定佐贺和ATAC在小鼠胚胎干细胞中的功能差异,
他们的区别。
这些目标一起为理解两个关键的
转录共激活因子佐贺和ATAC差异调节染色质动力学和转录。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Guy Poirier其他文献
Michael Guy Poirier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Guy Poirier', 18)}}的其他基金
Mechanisms of chromatin regulation of transcription
染色质转录调控机制
- 批准号:
10686218 - 财政年份:2021
- 资助金额:
$ 34.87万 - 项目类别:
Mechanisms of chromatin regulation of transcription
染色质转录调控机制
- 批准号:
10490242 - 财政年份:2021
- 资助金额:
$ 34.87万 - 项目类别:
Mechanisms of chromatin regulation of transcription
染色质转录调控机制
- 批准号:
10768063 - 财政年份:2021
- 资助金额:
$ 34.87万 - 项目类别:
Understanding how two related mammalian histone acetyl transferase co-activators, SAGA and ATAC, differentially regulate chromatin dynamics and transcription
了解两种相关的哺乳动物组蛋白乙酰转移酶共激活剂 SAGA 和 ATAC 如何差异调节染色质动力学和转录
- 批准号:
10166672 - 财政年份:2020
- 资助金额:
$ 34.87万 - 项目类别:
Characterization of Four Histone H3 Modifications in the DNA-Histone Interface
DNA-组蛋白界面中四种组蛋白 H3 修饰的表征
- 批准号:
8215741 - 财政年份:2008
- 资助金额:
$ 34.87万 - 项目类别:
Characterization of Four Histone H3 Modifications in the DNA-Histone Interface
DNA-组蛋白界面中四种组蛋白 H3 修饰的表征
- 批准号:
7763218 - 财政年份:2008
- 资助金额:
$ 34.87万 - 项目类别:
相似海外基金
Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
- 批准号:
10727966 - 财政年份:2023
- 资助金额:
$ 34.87万 - 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
- 批准号:
10601761 - 财政年份:2023
- 资助金额:
$ 34.87万 - 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
- 批准号:
479754 - 财政年份:2023
- 资助金额:
$ 34.87万 - 项目类别:
Operating Grants
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 34.87万 - 项目类别:
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
- 批准号:
486467 - 财政年份:2022
- 资助金额:
$ 34.87万 - 项目类别:
Studentship Programs
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 34.87万 - 项目类别:
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
- 批准号:
RGPIN-2018-06089 - 财政年份:2022
- 资助金额:
$ 34.87万 - 项目类别:
Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 34.87万 - 项目类别:
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
- 批准号:
557615-2021 - 财政年份:2022
- 资助金额:
$ 34.87万 - 项目类别:
Postdoctoral Fellowships
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
- 批准号:
RGPIN-2018-03951 - 财政年份:2022
- 资助金额:
$ 34.87万 - 项目类别:
Discovery Grants Program - Individual